Alps Advisors Inc Recursion Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $97,650 - $235,013	14,818 Added 10.48%	156,214 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $70,155 - $152,926	15,385 Added 12.21%	141,396 $1.06 Million
Q1 2023 May 10, 2023	BUY	$6.42 - $9.64 $18,271 - $27,435	2,846 Added 2.31%	126,011 $840,000
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $236,115 - $418,807	32,977 Added 36.56%	123,165 $949,000
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $94,758 - $164,587	-12,102 Reduced 11.83%	90,188 $960,000
Q2 2022 Aug 11, 2022	SELL	$5.04 - $9.26 $359,795 - $661,052	-71,388 Reduced 41.1%	102,290 $833,000
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $67,365 - $197,176	-10,936 Reduced 5.92%	173,678 $1.24 Million
Q4 2021 Feb 09, 2022	BUY	$16.14 - $21.86 $2.98 Million - $4.04 Million	184,614 New	184,614 $3.16 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.